Journal of Innovations in Pharmaceutical and Biological Sciences · Vol. 4, No. 2 · 2017 · pp. 68–73 · ISSN 2395-1095 · e-ISSN 2349-2759

Validation of spectrophotometric dissolution method for modified release Trimetazidine pharmaceutical dosage form

Farzana Hasin, Md. Hasan Mukhlasy, Md. Iftekhar Hussain, Md. Mofazzal Hossain, Md. Mehedi Hasan

Department of Pharmacy, University of Asia Pacific, BangladeshBangladesh
Department of Pharmacy, Primeasia University, BangladeshBangladesh
Adjunct Lecturer, Department of Pharmacy, University of Information Technology and Sciences, BangladeshBangladesh
Asst. Professor, Department of Pharmacy, University of Information Technology and Sciences, BangladeshBangladesh
Lecturer, Department of Pharmacy, University of Information Technology and Sciences, BangladeshBangladesh

DOI: https://doi.org/10.56511/jipbs.2017.v4.i02.pp68-73.227 · Published 2017 · Licence: https://creativecommons.org/licenses/by-nc-sa/4.0 · © 2017 The Author(s)

Abstract

released) rate of release. The dissolution conditions comprised of USP II (Paddle), with a Dissolution medium (Phosphate Buffer pH 6.8.) with Revolution 75 rpm. Detection was carried out at 231± 1 nm. The linear regression analysis data for the calibration plots showed good linear relationship within the concentration range 0.00800 mg/ml-0.03200 mg/ml. The value of correlation coefficient was found to be 1.00. The recovery of trimetazidine hydrochloride was about 95–105%. Based on the test results of linearity, accuracy and precision the range of method is established 80%-120%. The method was validated as per ICH guidelines.

This article has no full-text file on the journal’s site, so what follows is its record — title, authors, abstract and references. The full text can be restored by uploading the article’s PDF in OJS.